Company: INMB
Filing Date: 2025-03-27
Form Type: 10-K
Source: 0001013762-25-003354
Chunk: 92

Company: Inmune Bio, Inc.
Filing Date: 2025-03-27
Form: 10-K
Item: Item 1
Chunk 92
---
aging unsolicited takeover proposals. Specifically, the rights issued under the stockholder rights
plan could cause significant dilution to a person or group that attempts to acquire us on terms not approved in advance by our board of
directors. The rights plan is not intended to prevent a takeover, and we believe it will enable all our stockholders to realize the full
potential value of their investment in the Company and protect the Company and its stockholders from efforts to obtain control of the
Company that are inconsistent with the best interests of the Company and its stockholders. The rights under the plan will expire on December
30, 2025, subject to a possible earlier expiration to the extent provided in the stockholder rights plan, unless extended.

Sales of our common
shares by our employees, including our executive officers, could cause the trading price of our common shares to fall or prevent it from
increasing for numerous reasons, and sales by such persons could be viewed negatively by other investors.

In accordance with the guidelines
specified under Rule 10b5-1 under the Exchange Act, as amended, equivalent legislation in applicable jurisdictions, and our policies regarding
equity transactions, a number of our employees, including executive officers, may adopt share trading plans pursuant to which they have
arranged to sell common shares from time to time in the future. Generally, sales of common shares, including sales under such plans, by
our executive officers and directors require public filings. Sales of our common shares by such persons could cause the price of our common
shares to fall or prevent it from increasing. If sales by employees, executive officers, or directors cause a substantial number of our
common shares to become available for purchase in the public market, the price of our common shares could fall or may not increase. Also,
sales by such personnel could be viewed negatively by holders and potential purchasers of our common shares.

53

ITEM 1B. UNRESOLVED STAFF COMMENTS

Not applicable.

ITEM 1C. CYBERSECURITY

Risk Management and Strategy

We have processes for assessing,
identifying and managing cybersecurity risks, which are built into our information technology function and are designed to help protect
our Company from cyber threats as well as secure our networks and systems. Such processes include safeguards, response plan, and review
of our policies and procedures to identify risks. We engage an external party to enhance our cybersecurity oversight.

Governance

Our Audit Committee of the
Board of Directors, or the Audit Committee, is responsible for overseeing cybersecurity